Needham Initiates LB Pharmaceuticals With Buy, $68 Target
Needham initiated coverage on LB Pharmaceuticals's stock with a rating of Buy and a price target of $68.00. The price target implies an upside of 82.4% from the Oct 1 close of $37.28.
Needham initiated coverage on LB Pharmaceuticals's stock with a rating of Buy and a price target of $68.00. The price target implies an upside of 82.4% from the Oct 1 close of $37.28.